Link to this page
The Drug-Drug Interactions Ontology
Last uploaded:
February 11, 2016
| Id | http://purl.obolibrary.org/obo/dinto_DB00528
http://purl.obolibrary.org/obo/dinto_DB00528
|
|---|---|
| Preferred Name | lercanidipine |
| Synonyms |
3-{1-[(3,3-diphenylpropyl)(methyl)amino]-2-methylpropan-2-yl} 5-methyl 2,6-dimethyl-4-(3-nitrophenyl)-1,4-dihydropyridine-3,5-dicarboxylate
C36H41N3O6
|
| Type | http://www.w3.org/2002/07/owl#Class |
All Properties
| prefLabel | lercanidipine
|
|---|---|
| label | lercanidipine
|
| ATCCode | C08CA13
|
| Definition | Lercanidipine is a calcium channel blocker of the dihydropyridine class.
It is sold under various commercial names including Zanidip.
|
| has pharmacological target | |
| inhibits | |
| type | |
| InChIKey | InChIKey=ZDXUKAKRHYTAKV-UHFFFAOYSA-N
|
| is metabolised by | |
| Synonym | 3-{1-[(3,3-diphenylpropyl)(methyl)amino]-2-methylpropan-2-yl} 5-methyl 2,6-dimethyl-4-(3-nitrophenyl)-1,4-dihydropyridine-3,5-dicarboxylate
C36H41N3O6
|
| xref |
ChemSpider:59276
PubChem Compound:65866
PubChem Substance:46508865
Wikipedia:http://en.wikipedia.org/wiki/Lercanidipine
PharmGKB:PA164769058
|
| CASRN | 100427-26-7
|
| prefixIRI | obo2:dinto_DB00528
|
| SMILES | COC(=O)C1=C(C)NC(C)=C(C1C1=CC(=CC=C1)[N+]([O-])=O)C(=O)OC(C)(C)CN(C)CCC(C1=CC=CC=C1)C1=CC=CC=C1
|
| may interact with | |
| InChI | InChI=1S/C36H41N3O6/c1-24-31(34(40)44-6)33(28-18-13-19-29(22-28)39(42)43)32(25(2)37-24)35(41)45-36(3,4)23-38(5)21-20-30(26-14-9-7-10-15-26)27-16-11-8-12-17-27/h7-19,22,30,33,37H,20-21,23H2,1-6H3
|
| DBBrand | lercanidipine [inn]
|
| subClassOf |
| Delete | Subject | Author | Type | Created |
|---|---|---|---|---|
| No notes to display |